... to usher along the most promising biotechnology pipelines. The company's latest investment is in stem cell research firm OncoMed Pharmaceuticals ( Banking on billions For OncoMed, the deal could eventually be worth billions of dollars, given that ...
http://www.fool.com/investing/general/2013/12/06/investments-by-celgene-smack-of-private-equity.aspx
http://www.fool.com/investing/general/2013/12/06/investments-by-celgene-smack-of-private-equity.aspx
No comments:
Post a Comment